stockportfolio.pro
Corcept Therapeutics Incorporated Net Income 2000–2025
Corcept Therapeutics Incorporated (CORT) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $98.17M | 12.9% | -29.7% |
| FY 2024 | $139.73M | 20.7% | +32.5% |
| FY 2023 | $105.50M | 21.9% | +4.2% |
| FY 2022 | $101.29M | 25.2% | -10.0% |
| FY 2021 | $112.51M | 30.7% | +6.1% |
| FY 2020 | $106.01M | 30.0% | +12.6% |
| FY 2019 | $94.18M | 30.7% | +24.9% |
| FY 2018 | $75.41M | 30.0% | -41.6% |
| FY 2017 | $129.12M | 81.1% | +1486.3% |
| FY 2016 | $8.14M | 10.0% | +227.0% |
| FY 2015 | $-6.41M | — | +79.6% |
| FY 2014 | $-31.38M | — | +31.8% |
| FY 2013 | $-46.01M | — | -20.9% |
| FY 2012 | $-38.05M | — | -17.6% |
| FY 2011 | $-32.35M | — | -24.6% |
| FY 2010 | $-25.97M | — | -28.8% |
| FY 2009 | $-20.17M | -69537.9% | -0.5% |
| FY 2008 | $-20.06M | — | -73.3% |
| FY 2007 | $-11.57M | — | +53.5% |
| FY 2006 | $-24.87M | — | -23.8% |
| FY 2005 | $-20.09M | — | -29.3% |
| FY 2004 | $-15.54M | — | -58.3% |
| FY 2003 | $-9.81M | — | +47.0% |
| FY 2002 | $-18.50M | — | -148.2% |
| FY 2001 | $-7.45M | — | -303.8% |
| FY 2000 | $-1.85M | — | — |
Source: Corcept Therapeutics Incorporated SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Corcept Therapeutics Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCorcept Therapeutics Incorporated — frequently asked questions
What is Corcept Therapeutics Incorporated's net income?
Corcept Therapeutics Incorporated (CORT) reported net income of $98.17M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Corcept Therapeutics Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.